Noninvasive tests and diagnostic pathways to MASH diagnosis in the United States: a retrospective observational study
This study highlights real-world diagnostic pathways among patients newly diagnosed with MASH, supporting previous findings that liver biopsies are infrequently used in favor of noninvasive methods.
Authors
- Anthony Hoovler (ORCID: https://orcid.org/0000-0002-8833-4923)
- Semiu O. Gbadamosi (ORCID: https://orcid.org/0000-0003-2048-2943)
- Brenna L. Brady (ORCID: https://orcid.org/0000-0003-3210-806X)
- Kristin Evans (ORCID: https://orcid.org/0000-0003-0987-1745)
Institutions
- Novo Nordisk (United States) (US)
- Novo Nordisk (United Kingdom) (GB)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1080/13696998.2025.2468582
- Citations
- 5
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.77